{
    "2018-03-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Roche Tecentriq Phase III Combo Study Meets Primary Endpoint",
                "features": {
                    "keywords": [
                        "Roche",
                        "Tecentriq",
                        "Phase III",
                        "Combo",
                        "Study",
                        "Meets",
                        "Primary",
                        "Endpoint"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "CVS appoints former Eli Lilly CFO as president of PBM business",
                "features": {
                    "keywords": [
                        "CVS",
                        "appoints",
                        "former",
                        "Eli Lilly",
                        "CFO",
                        "president",
                        "PBM",
                        "business"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmacy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Understanding Nektar Therapeuticsâ€™ Top-Line Performance",
                "features": {
                    "keywords": [
                        "Nektar",
                        "Therapeutics",
                        "Top-Line",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business",
                "features": {
                    "keywords": [
                        "CVS",
                        "Hire",
                        "Former",
                        "Eli Lilly",
                        "CFO",
                        "Run",
                        "Pharmacy",
                        "Benefit",
                        "Business"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmacy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "3 High-Quality Dividend-Payers Selling at a Discount",
                "features": {
                    "keywords": [
                        "High-Quality",
                        "Dividend-Payers",
                        "Selling",
                        "Discount"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}